Aichi, Japan

Kenji Kawamura


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Aichi, JP (1991 - 1994)
  • Isukuba, JP (1999)

Company Filing History:


Years Active: 1991-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kenji Kawamura: Innovator in Antifungal and Antitumor Research

Introduction

Kenji Kawamura is a prominent inventor based in Aichi, Japan. He has made significant contributions to the fields of antifungal and antitumor research. With a total of 5 patents to his name, Kawamura has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Kawamura's latest patents include groundbreaking work on antifungal substances, specifically BE-49385, and the process for their production. He has also developed a novel antitumor substance, BE-13793C, which is represented by a specific chemical formula. This substance is recognized for its potential as an anticancer agent, and it is accompanied by a method of production and a microorganism, Streptoverticillium FERM P-10489, capable of producing this novel substance.

Career Highlights

Throughout his career, Kawamura has been associated with Banyu Pharmaceutical Co. Ltd., where he has focused on developing innovative pharmaceutical solutions. His work has not only advanced scientific understanding but has also contributed to the development of new therapeutic agents.

Collaborations

Kawamura has collaborated with notable colleagues, including Hiroyuki Suda and Katuhisa Kojiri. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.

Conclusion

Kenji Kawamura's contributions to antifungal and antitumor research highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for new treatments and advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…